Inhibrx (INBX) Stock Chart & Stock Price History $13.16 +0.09 (+0.69%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$13.16 0.00 (0.00%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inhibrx Stock Price Performance The Inhibrx (INBX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.76%, with a year-to-date return of -14.55%. In the past month, the stock has increased 10.87%, reflecting recent market activity. As of the latest close, Inhibrx traded at $13.16 with a market cap of $190.50 million and volume of 162,680 shares. Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.73%1 Month Performance+10.87%3 Month Performance+4.78%Year-To-Date Performance-14.55%1 Year Performance-61.76% INBX Stock Chart for Thursday, May, 22, 2025 INBX Chart by TradingView Inhibrx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$13.07$13.16+0.69%$13.55$12.52162,680 shs$190.50 million05/20/2025$12.47$13.07+4.81%$13.18$12.38194,274 shs$189.20 million05/19/2025$12.33$12.47+1.14%$12.64$12.15113,857 shs$180.52 million05/16/2025$12.02$12.33+2.58%$12.48$12.0354,679 shs$178.49 million05/15/2025$10.84$12.02+10.89%$12.32$10.9771,747 shs$174.00 million05/14/2025$11.28$10.84-3.90%$11.31$10.8477,206 shs$156.92 million05/13/2025$11.71$11.28-3.67%$11.87$11.19100,704 shs$163.29 million05/12/2025$11.18$11.71+4.74%$11.92$11.5263,445 shs$169.51 million05/09/2025$11.26$11.18-0.71%$11.98$11.1577,931 shs$161.84 million05/08/2025$11.10$11.26+1.44%$11.96$10.90108,318 shs$163 million Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$12.44$11.10-10.77%$12.60$11.0381,305 shs$160.68 million05/06/2025$12.33$12.44+0.89%$12.57$11.99165,443 shs$180.08 million05/05/2025$12.15$12.33+1.48%$12.54$11.73179,402 shs$178.49 million05/02/2025$12.32$12.15-1.38%$12.51$11.88122,946 shs$175.88 million05/01/2025$12.33$12.32-0.08%$12.82$12.0986,311 shs$178.34 million04/30/2025$11.72$12.33+5.20%$12.52$11.43103,133 shs$178.49 million04/29/2025$12.35$11.72-5.10%$12.28$11.13208,368 shs$169.66 million04/28/2025$12.26$12.35+0.73%$12.80$12.2385,402 shs$178.78 million04/25/2025$11.98$12.26+2.34%$12.82$11.8441,757 shs$177.48 million04/24/2025$12.16$11.98-1.48%$12.74$11.8845,789 shs$173.42 million04/23/2025$11.87$12.16+2.44%$12.69$12.0051,435 shs$176.03 million04/22/2025$11.38$11.87+4.31%$11.95$11.4052,139 shs$171.83 million04/21/2025$11.47$11.38-0.78%$11.72$11.22149,984 shs$164.74 million Related Companies Trevi Therapeutics Stock Price Chart Pharming Group Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Dianthus Therapeutics Stock Price Chart Iovance Biotherapeutics Stock Price Chart Arbutus Biopharma Stock Price Chart Akebia Therapeutics Stock Price Chart Zhengye Biotechnology Stock Price Chart Evolus Stock Price Chart Xencor Stock Price Chart Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INBX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.